These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

372 related articles for article (PubMed ID: 32348727)

  • 1. Pooled In Vitro and In Vivo CRISPR-Cas9 Screening Identifies Tumor Suppressors in Human Colon Organoids.
    Michels BE; Mosa MH; Streibl BI; Zhan T; Menche C; Abou-El-Ardat K; Darvishi T; Członka E; Wagner S; Winter J; Medyouf H; Boutros M; Farin HF
    Cell Stem Cell; 2020 May; 26(5):782-792.e7. PubMed ID: 32348727
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Genome-Scale CRISPR Screening in Human Intestinal Organoids Identifies Drivers of TGF-β Resistance.
    Ringel T; Frey N; Ringnalda F; Janjuha S; Cherkaoui S; Butz S; Srivatsa S; Pirkl M; Russo G; Villiger L; Rogler G; Clevers H; Beerenwinkel N; Zamboni N; Baubec T; Schwank G
    Cell Stem Cell; 2020 Mar; 26(3):431-440.e8. PubMed ID: 32142663
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A Novel Screening Approach for the Dissection of Cellular Regulatory Networks of NF-κB Using Arrayed CRISPR gRNA Libraries.
    O'Shea P; Wildenhain J; Leveridge M; Revankar C; Yang JP; Bradley J; Firth M; Pilling J; Piper D; Chesnut J; Isherwood B
    SLAS Discov; 2020 Jul; 25(6):618-633. PubMed ID: 32476557
    [TBL] [Abstract][Full Text] [Related]  

  • 4. CRISPR-Cas9-mediated gene knockout in intestinal tumor organoids provides functional validation for colorectal cancer driver genes.
    Takeda H; Kataoka S; Nakayama M; Ali MAE; Oshima H; Yamamoto D; Park JW; Takegami Y; An T; Jenkins NA; Copeland NG; Oshima M
    Proc Natl Acad Sci U S A; 2019 Jul; 116(31):15635-15644. PubMed ID: 31300537
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A Protocol for Multiple Gene Knockout in Mouse Small Intestinal Organoids Using a CRISPR-concatemer.
    Merenda A; Andersson-Rolf A; Mustata RC; Li T; Kim H; Koo BK
    J Vis Exp; 2017 Jul; (125):. PubMed ID: 28745625
    [TBL] [Abstract][Full Text] [Related]  

  • 6. CRISPR/Cas 9 genome editing and its applications in organoids.
    Driehuis E; Clevers H
    Am J Physiol Gastrointest Liver Physiol; 2017 Mar; 312(3):G257-G265. PubMed ID: 28126704
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Gene Therapy with CRISPR/Cas9 Coming to Age for HIV Cure.
    Soriano V
    AIDS Rev; 2017; 19(3):167-172. PubMed ID: 29019352
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Generating and Utilizing Murine Cas9-Expressing Intestinal Organoids for Large-Scale Knockout Genetic Screening.
    Kashfi H; Jinks N; Nateri AS
    Methods Mol Biol; 2020; 2171():257-269. PubMed ID: 32705648
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Modeling colorectal cancer using CRISPR-Cas9-mediated engineering of human intestinal organoids.
    Matano M; Date S; Shimokawa M; Takano A; Fujii M; Ohta Y; Watanabe T; Kanai T; Sato T
    Nat Med; 2015 Mar; 21(3):256-62. PubMed ID: 25706875
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A Perspective on the Future of High-Throughput RNAi Screening: Will CRISPR Cut Out the Competition or Can RNAi Help Guide the Way?
    Taylor J; Woodcock S
    J Biomol Screen; 2015 Sep; 20(8):1040-51. PubMed ID: 26048892
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Genome-scale deletion screening of human long non-coding RNAs using a paired-guide RNA CRISPR-Cas9 library.
    Zhu S; Li W; Liu J; Chen CH; Liao Q; Xu P; Xu H; Xiao T; Cao Z; Peng J; Yuan P; Brown M; Liu XS; Wei W
    Nat Biotechnol; 2016 Dec; 34(12):1279-1286. PubMed ID: 27798563
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Applications of kidney organoids derived from human pluripotent stem cells.
    Kim YK; Nam SA; Yang CW
    Korean J Intern Med; 2018 Jul; 33(4):649-659. PubMed ID: 29961307
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In vivo genome editing and organoid transplantation models of colorectal cancer and metastasis.
    Roper J; Tammela T; Cetinbas NM; Akkad A; Roghanian A; Rickelt S; Almeqdadi M; Wu K; Oberli MA; Sánchez-Rivera FJ; Park YK; Liang X; Eng G; Taylor MS; Azimi R; Kedrin D; Neupane R; Beyaz S; Sicinska ET; Suarez Y; Yoo J; Chen L; Zukerberg L; Katajisto P; Deshpande V; Bass AJ; Tsichlis PN; Lees J; Langer R; Hynes RO; Chen J; Bhutkar A; Jacks T; Yilmaz ÖH
    Nat Biotechnol; 2017 Jun; 35(6):569-576. PubMed ID: 28459449
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Multiplexed barcoded CRISPR-Cas9 screening enabled by CombiGEM.
    Wong AS; Choi GC; Cui CH; Pregernig G; Milani P; Adam M; Perli SD; Kazer SW; Gaillard A; Hermann M; Shalek AK; Fraenkel E; Lu TK
    Proc Natl Acad Sci U S A; 2016 Mar; 113(9):2544-9. PubMed ID: 26864203
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Modeling Breast Cancer Using CRISPR-Cas9-Mediated Engineering of Human Breast Organoids.
    Dekkers JF; Whittle JR; Vaillant F; Chen HR; Dawson C; Liu K; Geurts MH; Herold MJ; Clevers H; Lindeman GJ; Visvader JE
    J Natl Cancer Inst; 2020 May; 112(5):540-544. PubMed ID: 31589320
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Genome-scale CRISPR-Cas9 knockout and transcriptional activation screening.
    Joung J; Konermann S; Gootenberg JS; Abudayyeh OO; Platt RJ; Brigham MD; Sanjana NE; Zhang F
    Nat Protoc; 2017 Apr; 12(4):828-863. PubMed ID: 28333914
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Disease Modeling on Tumor Organoids Implicates AURKA as a Therapeutic Target in Liver Metastatic Colorectal Cancer.
    Boos SL; Loevenich LP; Vosberg S; Engleitner T; Öllinger R; Kumbrink J; Rokavec M; Michl M; Greif PA; Jung A; Hermeking H; Neumann J; Kirchner T; Rad R; Jung P
    Cell Mol Gastroenterol Hepatol; 2022; 13(2):517-540. PubMed ID: 34700030
    [TBL] [Abstract][Full Text] [Related]  

  • 18. CRISPR-Based Lentiviral Knockout Libraries for Functional Genomic Screening and Identification of Phenotype-Related Genes.
    Thomsen EA; Mikkelsen JG
    Methods Mol Biol; 2019; 1961():343-357. PubMed ID: 30912056
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A CRISPR Platform for Targeted In Vivo Screens.
    Maranda V; Zhang Y; Vizeacoumar FS; Freywald A; Vizeacoumar FJ
    Methods Mol Biol; 2023; 2614():397-409. PubMed ID: 36587138
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Chromosome Engineering of Human Colon-Derived Organoids to Develop a Model of Traditional Serrated Adenoma.
    Kawasaki K; Fujii M; Sugimoto S; Ishikawa K; Matano M; Ohta Y; Toshimitsu K; Takahashi S; Hosoe N; Sekine S; Kanai T; Sato T
    Gastroenterology; 2020 Feb; 158(3):638-651.e8. PubMed ID: 31622618
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.